Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2012
02/16/2012WO2012020022A1 6-cycloalkyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a inhibitors
02/16/2012WO2012020021A1 Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases
02/16/2012WO2012020019A1 Novel triterpene derivatives
02/16/2012WO2012020018A1 Product for the upper gastric sphere
02/16/2012WO2012020016A1 Crystalline form of pyrimidio[6,1-a]isoquinolin-4-one compound
02/16/2012WO2012020008A1 Inhibitors of bruton's tyrosine kinase
02/16/2012WO2012019991A1 Methods and pharmaceutical compositions for the treatment of hiv-1 infections
02/16/2012WO2012019990A2 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
02/16/2012WO2012019989A2 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
02/16/2012WO2012019984A1 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms
02/16/2012WO2012019970A1 Combination of glyt1 compound with antipsychotics
02/16/2012WO2012019966A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
02/16/2012WO2012019954A1 Pyrazolopyridine compounds as pde10a inhibitors
02/16/2012WO2012019930A1 Method for treating fatty liver diseases, in particular non-alcoholic steatohepatitis.
02/16/2012WO2012019772A1 Method for treating protozoan parasitic diseases
02/16/2012WO2012019633A1 Pharmaceutical granulate comprising imatinib mesylate
02/16/2012WO2012019496A1 C-aryl glucoside derivatives, preparation rpocess and pharmaceutical use thereof
02/16/2012WO2012019439A1 Huperzine a ophthalmic microemulsion and preparation method thereof
02/16/2012WO2012019430A1 Phthalazinone derivative, and preparation method and pharmaceutical use thereof
02/16/2012WO2012019428A1 Benzohydrol derivatives, a preparation process and pharmaceutical use thereof
02/16/2012WO2012019427A1 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
02/16/2012WO2012019426A1 Phthalazinone derivative, and preparation method and pharmaceutical use thereof
02/16/2012WO2012019381A1 Oral pharmaceutical composition containing inclusion of edaravone and cyclodextrin and preparation method thereof
02/16/2012WO2012019315A1 Novel trpv3 modulators
02/16/2012WO2012019295A1 Bioactive compounds in camel urine and milk
02/16/2012WO2012019284A1 Combinatory cancer treatment
02/16/2012WO2012019254A1 Derivatives of 6, 7-dihydro-3h-oxazolo [3, 4-a] pyrazine-5, 8- dione
02/16/2012WO2012007632A9 Use of edg2 inhibitors for treating rheumatoid arthritis
02/16/2012WO2011163610A3 Antimicrobial agents
02/16/2012WO2011160216A3 Compounds useful in imaging and therapy
02/16/2012WO2011154846A3 4, 6 -dibenzoylamino- 2 -methyl- pyrimidine derivatives and their use for the treatment of cancer
02/16/2012WO2011154553A3 Micrornas for the detection and isolation of human embryonic stem cell -derived cardiacv cell types
02/16/2012WO2011152809A3 Effervescent formulations comprising cephalosporin and clavulanic acid
02/16/2012WO2011151731A3 Surgical adjuvant composition and associated methods of use
02/16/2012WO2011143752A8 Use of aromatase inhibitors for synchronizing ovulation, inducing superovulation or double ovulation and improving twinning and fertility in a mammal
02/16/2012WO2011140655A8 Phenolic compositions derived from apple skin and uses thereof
02/16/2012WO2011138762A3 Cholesterol ester for reducing cholesterol absorption
02/16/2012WO2011137925A9 New pro-drugs of amaryllidaceae isocarbostyril products and their use against brain tumors
02/16/2012WO2011134444A9 Substitution derivatives of n6-benzyladenosine-5´-monophosphate, methods of preparation thereof, use thereof as medicaments, and therapeutic preparation containing these compounds
02/16/2012WO2011133707A3 Anti-viral compounds
02/16/2012WO2011132084A3 Therapeutic regimen and method for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency
02/16/2012WO2011127058A9 Biomarkers for mdm2 inhibitors for use in treating disease
02/16/2012WO2011125057A4 Cosmetic composition
02/16/2012WO2011115687A3 Alkylated sp-b peptoid compounds and related lung surfactant compositions
02/16/2012WO2011109113A9 Uses of beta-nicotinamide adenine dinucleotide
02/16/2012WO2011106105A9 Inhibitors for antiviral use
02/16/2012WO2011023465A3 Antimicrobial ether guanidines
02/16/2012WO2010141796A3 PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVES
02/16/2012WO2010054606A3 Triperpenoid 2 - deoxy glycosides and use thereof as medicaments
02/16/2012WO2002085309A9 Composition, formulations & kits for treatment of respiratory & lung disease with anti-sense oligonucleotides & a bronchodilating agent
02/16/2012US20120042398 Compositions for labeling and identifying autophagosomes and methods for making and using them
02/16/2012US20120041524 Compositions for Providing Vitamin D Year Round and Uses Thereof
02/16/2012US20120041397 Method of treatment of premalignant and malignant skin lesions with cytotoxic agents
02/16/2012US20120041155 Method of Preparing Carboxylic Acid Functionalized Polymers
02/16/2012US20120041074 Method of inducing neovascularization
02/16/2012US20120041073 Stabilized mutant opsin proteins
02/16/2012US20120041072 Antiviral agent
02/16/2012US20120041071 Tapentadol for treating pain due to osteoarthritis
02/16/2012US20120041070 Methods of treating cancer having an aberrant egfr or kras genotype
02/16/2012US20120041069 Sglt2 inhibitor dosage forms
02/16/2012US20120041068 Extended Release Pharmaceutical Preparations for Active Pharmaceutical Ingredients with pH Dependent Solubility
02/16/2012US20120041067 Methods of Inducing Terminal Differentiation
02/16/2012US20120041066 Medical foods for the treatment of developmentally-based neuropsychiatric disorders via modulation of brain glycine and glutathione pathways
02/16/2012US20120041065 Lauric acid distillate for animal feed
02/16/2012US20120041064 Skin treatment
02/16/2012US20120041063 Antitumoral compounds
02/16/2012US20120041062 Compound of salvianolic acid l, preparation method and use thereof
02/16/2012US20120041061 Use of prodrugs of gaba analogs for treating diseases
02/16/2012US20120041060 Treatment for altitudinal hypoxia
02/16/2012US20120041059 Bioactive compositions from theacea plants and processes for their production and use
02/16/2012US20120041058 Composition of traditional chinese medicine for reducing blood fat and preparation method thereof
02/16/2012US20120041057 SYNTHESIS AND CHARACTERIZATION OF C8 ANALOGS OF c-di-GMP
02/16/2012US20120041056 Nucleic acids specifically binding with human factor vii/viia and uses thereof
02/16/2012US20120041055 Composite polynucleic acid therapeutics
02/16/2012US20120041054 Compositions and methods for the treatment of sepsis and other disorders involving phospholipase a2 induction
02/16/2012US20120041053 DELIVERY OF dsRNA TO ARTHROPODS
02/16/2012US20120041052 Compositions and Methods to Treat Muscular & Cardiovascular Disorders
02/16/2012US20120041051 Compositions And Methods For Inhibiting Expression Of MIG-12 Gene
02/16/2012US20120041050 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
02/16/2012US20120041049 Design of small-interfering rna
02/16/2012US20120041048 COMPOSITIONS AND METHODS RELATING TO miR-31
02/16/2012US20120041047 Injectable Pharmaceutical Composition for Preventing, Stabilizing and/or Inhibiting Pathological Neovascularization-Related Conditions
02/16/2012US20120041046 Non-steroidal compounds for androgen receptor modulation
02/16/2012US20120041045 Use of pharmaceutical compositions containing mesembrenone
02/16/2012US20120041044 Process for the preparation of carvedilol and its enantiomers
02/16/2012US20120041043 Sulfonamide Compounds for the Treatment of Respiratory Disorders
02/16/2012US20120041042 Scent Ectoparasiticidal Formulation
02/16/2012US20120041041 5-hydroxy-benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
02/16/2012US20120041040 Functionalized 4- and 5-vinyl substituted regioisomers of 1, 2, 3-triazoles via 1, 3-dipolar cycloaddition and polymers thereof
02/16/2012US20120041039 Amine derivative compounds for treating ophthalmic diseases and disorders
02/16/2012US20120041038 Amine derivative compounds for treating ophthalmic diseases and disorders
02/16/2012US20120041037 Composition that comprises at least one oxime and its use in therapeutics
02/16/2012US20120041036 Substituted acylguanidine derivatives (as amended)
02/16/2012US20120041035 Levamlodipine compound pharmaceutical composition
02/16/2012US20120041034 Sustained release aminopyridine composition
02/16/2012US20120041033 Hydroxybenzoate salts of metanicotine compounds
02/16/2012US20120041032 Metalloprotein inhibitors
02/16/2012US20120041031 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists
02/16/2012US20120041030 Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action
02/16/2012US20120041029 Compositions for drug delivery
1 ... 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 ... 7860